Mental Health Clinics in Mililani, HI Accepting Medicare
28 Mental Health Clinics found. Showing 21 - 28
 Kamahele Bernard Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 95-390 Kuahelani Ave # 3ac-1128, Mililani, HI 96789 Phone: 808-428-0177 |
Brooke Maloney, Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 94-509 Hokuala St, Mililani, HI 96789 Phone: 808-979-1783 |
Exhale Therapy Hawaii, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 95-390 Kuahelani Ave # 3ac-1064, Mililani, HI 96789 Phone: 808-664-0638 |
Honolulu Counseling Llc Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 95-383 Lanikuhana Ave, Mililani, HI 96789 Phone: 808-392-6929 |
Integrated Healing Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 95-210 Kuauna Pl, Mililani, HI 96789 Phone: 808-364-9473 |
Danielle Hodges Psyd Llc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 95-390 Kuahelani Ave # 3ac-1119, Mililani, HI 96789 Phone: 808-489-0854 |
Child And Family Service Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 95-1091 Ainamakua Dr, Mililani, HI 96789 Phone: 808-476-3314 |
Michelle D. Tsuruda, Psyd, Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 Kahelu Ave Ste 232, Mililani, HI 96789 Phone: 808-383-9738 |
News Archive
UTMB researchers develop new vaccine against salmonella poisoning
Researchers from The University of Texas Medical Branch at Galveston have developed a vaccine against salmonella poisoning designed to be taken by mouth. The findings are detailed in an article published in Frontiers in Cellular and Infection Microbiology.
Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
Research could lead to new ways to combat chlamydia
A protein secreted by the chlamydia bug has a very unusual structure, according to scientists in the School of Medicine at The University of Texas Health Science Center San Antonio. The discovery of the protein's shape could lead to novel strategies for diagnosing and treating chlamydia, a sexually transmitted disease that infects an estimated 2.8 million people in the U.S. each year.
Tornier and LifeCell commence enrollment in Conexa Reconstructive Tissue Matrix clinical trial
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
› Verified 7 days ago
- 1
- 2(current)